Navigation Links
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
Date:2/13/2008

ysaccharides, also known as glycosaminoglycans or GAG. Hunter syndrome is one of several related lysosomal storage diseases.

In Hunter syndrome, cumulative build up of GAG in cells throughout the body interferes with the way certain tissues and organs function, leading to severe clinical complications and early mortality. Physical manifestations for some people with Hunter syndrome may include distinct facial features, a large head and an enlarged abdomen. People with Hunter syndrome may also experience hearing loss, thickening of the heart valves leading to a decline in cardiac function, obstructive airway disease, sleep apnea, and enlargement of the liver and spleen. In some cases, central nervous system involvement leads to progressive neurologic decline.

Shire Plc

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
2. Genzyme Receives Approval to Market Elaprase(R) in Japan
3. Clexane(R)/Lovenox(R) Approved in Japan
4. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
5. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
6. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
7. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
8. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
9. Biomoda Announces Collaborative Agreement With New Mexico Tech
10. Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean
11. Prestigious Bioethics Award for Scholar from Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... IRVINE, CA (PRWEB) April 01, 2015 ... in Personalized Medicine , presented two scientific posters ... City, Utah, last week. The four-day event was hosted ... 2,000 genetic specialists dedicated to educating genetic and genomic ... Biosciences presented Genetics and Insomnia: Study on the Role ...
(Date:4/1/2015)... 1, 2014 /CNW/ - Canada,s Research-Based ... (PMPRB) newly released report on Cost Drivers of Public Drug ... according to the report, the rates of change in drug ... low of -0.8 percent in 2012/13 for a number of ... that examines the costs of medicines without considering their overall ...
(Date:4/1/2015)... and NEW YORK ... Inc. (NASDAQ:  PTBI), a biopharmaceutical company advancing protein ... provided an overview of the Company,s 2014 achievements ... achievements below demonstrate the progress the Company has ... multiple corporate partnerships for its MuGard programs, the ...
(Date:4/1/2015)...  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... monetization of intellectual property, today announced that Chardan ... global investment bank specializing in micro, small, and ... Spherix. The report, authored by ... Chardan, was published on March 31, 2015. The ...
Breaking Biology Technology:Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015 2Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 5PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 6Chardan Capital Issues Industry Note Covering Spherix 2Chardan Capital Issues Industry Note Covering Spherix 3
... Million Gift, NEW YORK, April 16 NYU ... renamed the NYU Elaine,A. and Kenneth G. Langone Medical ... trustees and his wife, whose unrestricted $200 million gift ... announcement was made by Robert I. Grossman, M.D.,( http://www.med.nyu.edu/people/grossr03.html ...
... CITY, April 16 /PRNewswire-FirstCall/ - Victhom Human Bionics,Inc. ... the ongoing,human clinical trial of its Closed-Loop neuromodulation ... of patients suffering from foot drop,secondary to a ... the,initial results of the trial have demonstrated that ...
... and Finger Health in Diabetes Management, ... Pelikan,Technologies Inc., a leading developer of ... Lilly and Company today announced the,signing of ... of the,co-promotion agreement, the companies will promote ...
Cached Biology Technology:NYU Medical Center Changes Name to Honor Chairman of Board & Wife 2NYU Medical Center Changes Name to Honor Chairman of Board & Wife 3NYU Medical Center Changes Name to Honor Chairman of Board & Wife 4NYU Medical Center Changes Name to Honor Chairman of Board & Wife 5Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system 2Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education 2Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education 3Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education 4
(Date:3/18/2015)... 18, 2015 As mobile payments become ... smart wallets and apps continue to be introduced into the ... the mobile payment industry in focus today are:  NXT-ID, Inc. ... BABA ), Apple Inc. (NASDAQ: AAPL ... Inc. (NASDAQ: FB ) NXT-ID, Inc. ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
(Date:3/12/2015)... 2015 The mascots of the Atlantic Coast ... of Wake Forest Baptist Medical Center. They stopped by ... ACC Men,s Basketball Tournament. Young patients enjoyed bonding with ... their autographs. Brenner Children,s Hospital is the ... only children,s hospital in northwest North Carolina ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... pulmonary fibrosis (IPF) is a chronic and progressive lung disorder ... The disease is characterized by the insidious onset of dyspnea ... , Now, Selman and coworkers present in an article published ... May, strong evidence indicating that a subset of IPF patients ...
... at the first signs of cold weather. Rather, new research ... survive the chilly months. , These so-called "heat-shock proteins" ensure ... spring. , A study of flesh flies and a ... of protective heat-shock proteins that are turned on almost as ...
... for revealing anatomical details of soft tissues. Contrast agents ... allow physiological processes to be followed in real time. ... cannot reveal anatomic structures. As reported in the journal ... at Samsung Medical Center and Taeghwan Hyeon at Seoul ...
Cached Biology News:Extra-aggressive form of idiopathic pulmonary fibrosis identified 2For many insects, winter survival is in the genes 2For many insects, winter survival is in the genes 3